title: Sight-threatening diabetic eye disease: an update and review of the literature.
authors.affiliation: Moorfields Eye Hospital, London, UK.
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Symes
authors.affiliation: Moorfields Eye Hospital, London, UK.
authors.forename: Gerald
authors.initials: G
authors.lastname: Liew
authors.affiliation: Moorfields Eye Hospital, London, UK.
authors.forename: Adnan
authors.initials: A
authors.lastname: Tufail
mesh_terms: D000553:Ambulatory Care / Q000379:methods*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001794:Blood Pressure; D003930:Diabetic Retinopathy / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D004739:England / Q000453:epidemiology; D006442:Glycated Hemoglobin; D006801:Humans; D008028:Light Coagulation; D000069579:Ranibizumab; D012017:Referral and Consultation / Q000706:statistics & numerical data; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D015351:Vision Screening; D014852:Wales / Q000453:epidemiology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D006442:Glycated Hemoglobin; D000069579:Ranibizumab; D042461:Vascular Endothelial Growth Factor A; C467484:VEGFA protein, human; C517652:hemoglobin A1c protein, human